Cardiovascular Ultrasound Market to Reach $4,171.12 million by 2032, exhibiting a CAGR of 5.8% from 2023 to 2032

PORTLAND, IL, UNITED STATES, March 17, 2025 /EINPresswire.com/ -- According to the report, the global cardiovascular ultrasound market was valued for $2,369.27 million in 2022, and is projected to reach $4,171.12 million by 2032, registering a CAGR of 5.8% from 2023 to 2032.

Rise in prevalence of chronic cardiovascular diseases such as coronary artery disease, cardiac arrythmias, and others is anticipated to boost the growth of market. However, high cost of echocardiography is anticipated to hinder the growth of market. On the contrary, technological advancement in the healthcare sector is expected to witness growth during the forecast period.

Request Sample of the Report on - https://www.alliedmarketresearch.com/request-sample/2827

Want to Explore More, Connect to our Analyst- https://www.alliedmarketresearch.com/connect-to-analyst/2827

The transthoracic echocardiogram segment to maintain its leadership status throughout the forecast period.

Based on type, the transthoracic echocardiogram segment held the highest market share in 2022, accounting for more than half of the global cardiovascular ultrasound market revenue and is estimated to maintain its leadership status throughout the forecast period, owing to the high presence of market players who manufacture transthoracic echocardiogram system. However, the transesophageal echocardiogram segment is projected to manifest significant growth with a CAGR of 6.7% from 2023 to 2032, owing to the increase in adoption of transesophageal echocardiogram by healthcare providers for early diagnosis of disease.

The 2D segment to maintain its leadership status throughout the forecast period.

Based on technology, the 2D segment held the highest market share in 2022, accounting for more than half of the global cardiovascular ultrasound market revenue and is estimated to maintain its leadership status throughout the forecast period, owing to high adoption of 2D echocardiogram by healthcare providers. However, the 3D and 4D segment is projected to manifest a significant CAGR of 6.4% from 2023 to 2032, owing to technological advancement in the healthcare sector.

The color segment to maintain its leadership status throughout the forecast period.

Based on display type, the color segment held the highest market share in 2022, accounting for more than four-fifths of the global cardiovascular ultrasound market revenue and is estimated to maintain its leadership status throughout the forecast period, owing to clear visualization of cardiac images. However, the same segment is projected to manifest a significant CAGR of 5.9% from 2023 to 2032, owing to high technological advancement throughout the forecast period.

The hospitals segment to maintain its leadership status throughout the forecast period.

Based on end user, the hospitals segment held the highest market share in 2022, accounting for more than half of the global cardiovascular ultrasound market revenue and is estimated to maintain its leadership status throughout the forecast period, owing to rise in prevalence of cardiovascular diseases. However, the cardiac centers segment is projected to manifest a significant CAGR of 6.4% from 2023 to 2032.

For Procurement Information- https://www.alliedmarketresearch.com/purchase-enquiry/2827

North America to maintain its dominance by 2032.

Based on region, North America held the highest market share in terms of revenue in 2022, accounting for more than two-fifths of the global cardiovascular ultrasound market revenue. This is attributed to high presence of cardiovascular ultrasound drug manufacturers in North America and rising prevalence of chronic disease such as cancer and chronic pain. However, the Asia-Pacific region is expected to witness the fastest CAGR of 6.6% from 2023 to 2032 and is likely to dominate the market during the forecast period, owing to rising number of geriatric populations, as geriatric population is more susceptible to cardiovascular diseases and increase in awareness among the people regarding cardiovascular ultrasound.

Leading Market Players: -

Canon Medical Systems Corporation
Esaote SpA
GE Healthcare
Koninklijke Philips
Siemens Healthineers
Hitachi
Samsung Healthcare
Whale Imaging
FujiFilm
Mindray

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
Allied Market Research
+ 1800-792-5285
email us here
Visit us on social media:
Facebook
X
LinkedIn
YouTube